Immunoblotting of cell lysates from two primary MM samples revealed that combination treatment with BTZ (10 nM) + MX69 (20 μM) downregulated MDM2 and XIAP, and upregulated NOXA (Figure 4A). This evidence concerns the gene MDM2 and Miyoshi myopathy.